Cytoplasmic p21 is a potential predictor for cisplatin sensitivity in ovarian cancer - Wikidata - awgldk - TriplyDB

Cytoplasmic p21 is a potential predictor for cisplatin sensitivity in ovarian cancer

Cytoplasmic p21 is a potential predictor for cisplatin sensitivity in ovarian cancer

http://www.wikidata.org/entity/Q34024735

about

Resistance and gain-of-resistance phenotypes in cancers harboring wild-type p53 Cytoplasmic localization of p21 protects trophoblast giant cells from DNA damage induced apoptosis.Loss of compensatory pro-survival and anti-apoptotic modulator, IKKε, sensitizes ovarian cancer cells to CHEK1 loss through an increased level of p21.Infiltrating mast cells increase prostate cancer chemotherapy and radiotherapy resistances via modulation of p38/p53/p21 and ATM signals Normalizing to GADPH jeopardises correct quantification of gene expression in ovarian tumours - IPO8 and RPL4 are reliable reference genes.Mechanistic added value of a trans-Sulfonamide-Platinum-Complex in human melanoma cell lines and synergism with cis-Platin Prognostic significance of several biomarkers in epithelial ovarian cancer: a meta-analysis of published studies.Activating adaptive cellular mechanisms of resistance following sublethal cytotoxic chemotherapy: implications for diagnostic microdosing.Less understood issues: p21(Cip1) in mitosis and its therapeutic potential.PRMT6 increases cytoplasmic localization of p21CDKN1A in cancer cells through arginine methylation and makes more resistant to cytotoxic agents Adenovirus type 12 E1B 55-kilodalton oncoprotein promotes p53-mediated apoptotic response of ovarian cancer to cisplatin.Small double-stranded RNA mediates the anti-cancer effects of p21WAF1/ClP1 transcriptional activation in a human glioma cell line.Differentially expressed genes and gene networks involved in pig ovarian follicular atresia.The opposite prognostic significance of nuclear and cytoplasmic p21 expression in resectable gastric cancer patients.Mesenchymal Stem Cells Facilitate In Vitro Development of Human Preantral Follicle.The influence of simulated microgravity on proliferation and apoptosis in U251 glioma cells.FGF1 induces resistance to chemotherapy in ovarian granulosa tumor cells through regulation of p53 mitochondrial localization.Emerging diagnostic, prognostic and therapeutic biomarkers for ovarian cancer.

P2860

Q27006998-B4BEA02C-86FC-49F8-BB4B-330DDE6DD1D9 Q33644593-0311EA37-0FA5-4C20-A1AF-2DB7A71494F3 Q35149603-F664576D-8BC5-4B54-AD0B-3AD005E042BD Q36738823-1E9E4AFF-99E4-4170-9ECB-45FAC6880D2D Q37153731-F66F8B98-BF0E-4140-B659-DD7DB5280127 Q37663479-DFA90257-3A27-4E6B-BFEF-D738764E7D5F Q38099749-FDBD47F5-7DA5-4E6C-B6C3-F5DDABEB2764 Q38186660-0B4C7ADE-993C-437F-B8FE-8101B4727900 Q38214413-7274E458-D178-4B7B-BE81-119DECE139A3 Q38260494-80D3AD00-DBD2-48FF-9614-77D07997F83F Q38893456-A916F8BA-69FF-4065-B4DF-0AD268122574 Q39023357-BC719A11-661F-40B0-B4B6-1AD8AAE36633 Q39035475-C530B03C-0D9E-4346-874B-0A0898C9670E Q39078294-DF3F985E-D9D2-40BA-AF46-EDBFAA4F3B70 Q48581587-F39382E4-4336-4A91-A09D-490C3486B686 Q48721905-A2242695-65E7-4948-AC3A-1276A12558C6 Q52691547-C8D6B167-E71F-417B-902F-8E5C106C81DC Q52941950-94B491B5-08CC-4D85-BF07-3FCB52FE0FEA

P2860

Cytoplasmic p21 is a potential predictor for cisplatin sensitivity in ovarian cancer

http://www.wikidata.org/entity/Q34024735

description

2011 nî lūn-bûn

@nan

2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Cytoplasmic p21 is a potential predictor for cisplatin sensitivity in ovarian cancer

@ast

Cytoplasmic p21 is a potential predictor for cisplatin sensitivity in ovarian cancer

@en

Cytoplasmic p21 is a potential predictor for cisplatin sensitivity in ovarian cancer

@nl

type

label

Cytoplasmic p21 is a potential predictor for cisplatin sensitivity in ovarian cancer

@ast

Cytoplasmic p21 is a potential predictor for cisplatin sensitivity in ovarian cancer

@en

Cytoplasmic p21 is a potential predictor for cisplatin sensitivity in ovarian cancer

@nl

prefLabel

Cytoplasmic p21 is a potential predictor for cisplatin sensitivity in ovarian cancer

@ast

Cytoplasmic p21 is a potential predictor for cisplatin sensitivity in ovarian cancer

@en

Cytoplasmic p21 is a potential predictor for cisplatin sensitivity in ovarian cancer

@nl

P1433

Q34024735-6A6D1F64-89AF-4A7F-B923-9FAED328D88D

P1476

Q34024735-5433F4A4-99DB-4E76-AAB4-4E5F45E9466B

P2093

Q34024735-0579D665-0923-4CBC-A47A-D590F79650FA

Q34024735-0C628D87-167D-46DA-8DB4-0E0C706252F3

Q34024735-0CE5E25A-282F-4387-AA33-3A35636E4F53

Q34024735-18D3100D-C8BE-49E1-81B7-566B6A7DB18A

Q34024735-4587E950-46D7-4248-9922-601F880B82DC

Q34024735-521FC3C0-0FC5-4298-A2B7-023AD89EBFA8

Q34024735-620EFF82-B713-4914-853D-EB4E56255C84

Q34024735-6A78B189-B843-4943-A0A7-1F8D10726256

Q34024735-73E17A11-FE86-4D46-85E4-1B86FED42053

Q34024735-763B4342-D372-4B68-BEC8-F6134933A36A

P2860

Q34024735-030F7061-FA4D-4ACF-AE21-1A282878B0F9

Q34024735-074895C3-6016-4E8F-9B8E-792788E671FB

Q34024735-0F736C77-0CE4-4767-A641-A78D982579F7

Q34024735-111D8CC1-BF3B-4C4B-8AEA-6C94F3B07C81

Q34024735-15A9A159-AAA8-4EA2-BABE-1032828B3461

Q34024735-175B06B0-D871-4C8A-943D-A19B39DA1D2A

Q34024735-1A9ACEA0-B5F5-4CB6-AC3A-9ED7A88D4892

Q34024735-37B27316-8E8C-46AB-97B5-D395E273E85B

Q34024735-4BC39095-3FC3-4715-9461-1C125C9CB21F

Q34024735-4EDD1A3B-5293-4C8A-9DBC-C8D73697F0A1

P2888

Q34024735-33172639-BE6A-4E97-8E7D-55189EBAC7DB

P304

Q34024735-6A5A7276-193E-4084-A95C-201C9D6C2425

P31

Q34024735-6C5715CA-4B75-4EED-AABE-1B41983B96F3

P356

Q34024735-524DCB63-9A37-4080-AA08-A4402E8F5F7C

P407

Q34024735-063A1B3D-BBAC-4707-9E10-8F9B7E8517CB

P478

Q34024735-B138F64C-E9A6-4D21-B611-FD3BAF0F77F9

P50

Q34024735-84C0776F-0D53-4206-8CB1-2510EC44C732

P577

Q34024735-6EBB13A6-220C-4488-A0AB-20D7F5B0B092

P5875

Q34024735-7CB0628E-4A64-4932-9284-A569E729F20C

P6179

Q34024735-D4679EF6-8C1F-43A4-BB35-7B9258F75BE6

P698

Q34024735-E2954051-9B25-4D68-A822-C74DA7572EAD

P921

Q34024735-2C1C2396-8792-4FA0-A2FB-E05843537539

P932

Q34024735-2164BCE5-F368-48A2-BAE5-7C4B7F787623

P356

1471-2407-11-399

P1433

P1476

Cytoplasmic p21 is a potential predictor for cisplatin sensitivity in ovarian cancer

@en

P2093

Danhui Weng

http://www.w3.org/2001/XMLSchema#string

Ding Ma

http://www.w3.org/2001/XMLSchema#string

Gang Xu

http://www.w3.org/2001/XMLSchema#string

Hongbin Xu

http://www.w3.org/2001/XMLSchema#string

Jianfeng Zhou

http://www.w3.org/2001/XMLSchema#string

Kezhen Li

http://www.w3.org/2001/XMLSchema#string

Li Meng

http://www.w3.org/2001/XMLSchema#string

Pingbo Chen

http://www.w3.org/2001/XMLSchema#string

Quanfu Ma

http://www.w3.org/2001/XMLSchema#string

Ronghua Liu

http://www.w3.org/2001/XMLSchema#string

P2860

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases

AKT/PKB signaling: navigating downstream

Cytoplasmic p21WAF1/CIP1 expression is correlated with HER-2/ neu in breast cancer and is an independent predictor of prognosis

The phosphatidylinositol 3-Kinase AKT pathway in human cancer

Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells.

Quantitative p21(waf-1)/p53 immunohistochemical analysis defines groups of primary invasive breast carcinomas with different prognostic indicators.

Implication of the Akt2/survivin pathway as a critical target in paclitaxel treatment in human ovarian cancer cells.

Modern pathology: prognostic parameters in squamous cell carcinoma of the esophagus.

Oncogenic functions of tumour suppressor p21(Waf1/Cip1/Sdi1): association with cell senescence and tumour-promoting activities of stromal fibroblasts.

Role of X-linked inhibitor of apoptosis protein in chemoresistance in ovarian cancer: possible involvement of the phosphoinositide-3 kinase/Akt pathway.

P2888

1471-2407-11-399

P304

399

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-11-399

http://www.w3.org/2001/XMLSchema#string

P407

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-09-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51657339

http://www.w3.org/2001/XMLSchema#string

P6179

1000177631

http://www.w3.org/2001/XMLSchema#string

P698

21933447

http://www.w3.org/2001/XMLSchema#string

P921

P932

3184122

http://www.w3.org/2001/XMLSchema#string